Immersive Virtual Reality in Cognitive Rehabilitation of Patients With Post-Stroke Cognitive Impairment

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Chile

About this trial

This pilot study aims to evaluate the feasibility of implementing immersive virtual reality (VR) in cognitive rehabilitation for adults with post-stroke cognitive impairment receiving outpatient therapy. Participants will use a head-mounted display and interactive software to engage in gamified cognitive exercises that simulate memory, attention, and executive function tasks. The intervention consists of 10 sessions, delivered two to three times per week over a period of approximately four weeks. The study will assess multiple feasibility indicators, including the recruitment rate based on eligibility criteria, the safety and tolerability of VR sessions for participants, and the usability and satisfaction reported by occupational therapists administering the intervention. Additionally, exploratory outcomes include changes in global cognition and specific cognitive domains, as well as self-reported quality of life. Adverse effects related to VR use will be tracked. This pilot study will help inform the design and implementation of future, larger-scale clinical trials.

Eligibility criteria

Qualifiers

Patients over 18 years of age

Patients with a cerebrovascular accident of any etiology with less than 3 months of progression

Patients with mild to moderate cognitive impairment post-stroke (impairment in at least one cognitive domain)

MoCA score of less than 24 points

Disqualifiers

Patients with refractive errors that prevent the use of the headset

Patients with any type of aphasia that prevents the administration of the MoCA test

Patients with severe psychiatric disorders (presence of psychotic symptoms or derealization)

Patients with severe motor impairments (lack of trunk control or global strength of both upper limbs < M3)

Trial design

Treatments tested in this trial

  • Kinesix XR on Meta Quest 3

Treatment groups

20 Participants
are divided into 1 treatment group

Sponsors and collaborators